Bad debts accumulated by China’s state banks have been targeted by distressed asset investors for about a decade, with mixed results. The high-profile auctions of the mid-2000s that attracted the likes of Avenue Capital and Mellon are no more. Foreign investors are enjoying the most success on the fringes, pursuing assets on a smaller scale in lesser known areas.
The four asset management corporations (AMCs) set up to handle bad debts emanating from the Big Four state banks, still have about $100 billion in legacy assets on their books, much of it from 10 years...
Singapore sovereign wealth fund GIC Private saw its returns slow over the past year and warned the combination of high asset valuations, low interest rates and uncertain growth is likely to weigh on performance over at least the next decade.
India's Green House Ventures (GHV) Accelerator will partner with Japan and US-based early-stage investor World Innovation Labs (WiL) to launch a INR3.5 billion ($52 million) fund for investments in Indian start-ups.
KKR will exit India-based Gland Pharma as Shanghai Fosun Pharmaceutical acquires a majority stake in the business for up to $1.26 billion. KKR’s share of the proceeds will be $576.3 million, more than twice what it invested in Gland in 2014.
World Innovation Lab (WiL) has led a JPY1.1 billion ($10.6 million) investment in Japanese social media-oriented restaurant guide operator Retty.